PATENT CLAIM ANALYSIS

Application Number: 15997422
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
A method for promoting conversion of cells into cardiomyocytic tissue is carried out by contacting fibrotic tissue (e.g., scar tissue) with a microRNA oligonucleotide or combination of microRNA oligonucleotides. The methods lead to direct reprogramming of fibroblasts to cardiomyocytes or cardiomyoblasts.

Claim (Index 5):
The method of  claim 1 , wherein said cell is directly reprogrammed into cardiomyocytic tissue without a stem cell intermediary state.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 94.0
- Lexical Diversity: 1.21053
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13808311', '14440567', '15036357', '15853095', '14368149']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7530771685501553
- 35 USC 102 Novelty (BERT): 0.6975245482665535
- Combined Prediction Score: 0.7475219065217952
- Mean Citation Score: 348.7022100000001
- Max Citation Score: 730.46484
- Similarity Product: 705.7274923164653

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test